Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib (Q87876744)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

Tetsuhiro Kasamatsu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Takayuki Saitoh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Rumi Ino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Nanami Gotoh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Takeki Mitsui

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Hiroaki Shimizu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Morio Matsumoto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Morio Sawamura

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Akihiko Yokohama

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Hiroshi Handa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Norifumi Tsukamoto

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Hirokazu Murakami

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

1 reference

13 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

published in

Hematological Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

711-718

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

Role of interleukin 6 in the growth of myeloma-derived cell lines

18 March 2020

cites work

1 reference

7 January 2021

Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma

1 reference

7 January 2021

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

1 reference

7 January 2021

Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells

1 reference

7 January 2021

Interleukin-10: new perspectives on an old cytokine

1 reference

7 January 2021

Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site

1 reference

7 January 2021

IL-10R polymorphisms are associated with very-early-onset ulcerative colitis

1 reference

7 January 2021

Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS.

1 reference

7 January 2021

Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor

1 reference

7 January 2021

Association of IL-10 and IL-10Rbeta gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor

1 reference

7 January 2021

IL-10RB rs2834167 (A/G) polymorphism is associated with the susceptibility to systemic lupus erythematosus: evidence from a study in Chinese Han population

1 reference

7 January 2021

Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population

1 reference

7 January 2021

Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis

1 reference

7 January 2021

Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America

1 reference

7 January 2021

Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma

1 reference

7 January 2021

Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines

1 reference

7 January 2021

Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

1 reference

7 January 2021

Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis

1 reference

7 January 2021

Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence

1 reference

7 January 2021

IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma

1 reference

7 January 2021

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma

1 reference

7 January 2021

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

1 reference

7 January 2021

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

1 reference

7 January 2021

IL10 receptor is a novel therapeutic target in DLBCLs.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.2322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27405747%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference